Govt to boost supervision of vaccines

Top drug regulator says more efforts will ensure safety for public health

China will intensify supervision of vaccines, including inspection of the products, to ensure safety of public health this year, the top drug regulator said.

The National Medical Products Administration will urge its branches across the country to improve supervision, and will supervise handling of cases involving legal violations or irregularities, Jiao Hong, head of the administration, said at a national conference on drug supervision that concluded on Friday. Improving supervision of vaccines will be a priority for the administration for the new year, she said.